Heart drug combo pill tested for easier dosing

NCT ID NCT07444164

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 1 trial tested whether a single capsule containing 90 mg ticagrelor and 100 mg aspirin works the same in the body as taking the two drugs separately. Twenty-four healthy adults in Mexico participated. The study measured how much of each drug reached the bloodstream and how fast the body cleared them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ticagrelor and acetylsalicylic acid (aspirin) in a single capsule

What this could lead to

If successful, this could lead to a simpler, single-pill option for patients who need both ticagrelor and aspirin.

What could go wrong

This is an early-stage study in only 24 healthy people, so results may not predict how the drug works in patients or reveal all side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centro de Estudios Científicos y Clínicos Pharma S.A. de C.V.

    Xochitepec, Morelos, 627790, Mexico